Short term relapse risk after switching from natalizumab to ocrelizumab or cladribine - an international cohort study
Johanna Treffts,Yan Van Kesteren,Sandra Thiel,Alexander Stahmann,Melinda Magyari,Achim Berthele,Katrin Giglhuber,Stefan Bittner,Erik Ellwardt,Klemens Angstwurm,Bjorn Tackenberg,Jan Jurs,Andrea Viehover,Luisa Klotz,Lena Theis,Ralf Gold,David Ellenberger,Kerstin Hellwig Neurology(2021)
AI 理解论文
溯源树
样例